Earl Douglas

Earl Douglas

Compliance Officer chez ALLOGENE THERAPEUTICS, INC.

Fortune : 2 M $ au 31/03/2024

61 ans
Health Technology
Finance
Consumer Services

Profil

Earl M.
Douglas
is currently working as the Secretary, Compliance Officer & General Counsel at Allogene Therapeutics, Inc. He previously held the position of Vice President & General Counsel at BioMimetic Therapeutics, Inc. from 2011 to 2012, at OPX Biotechnologies, Inc. from 2012 to 2015, at Spinal Dynamics Corp.
from 2000 to 2002, and at Smith + Nephew, Inc. from 1995 to 2000.
He also served as the General Counsel at Kiverdi, Inc. and as the Secretary, Executive VP & General Counsel at Applied Molecular Transport, Inc. Mr. Douglas obtained his undergraduate degree from Massachusetts Institute of Technology and his graduate degree from Columbia Law School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/01/2024 477 634 ( 0,28% ) 2 M $ 31/03/2024

Postes actifs de Earl Douglas

SociétésPosteDébut
ALLOGENE THERAPEUTICS, INC. Compliance Officer 14/08/2023
Tous les postes actifs de Earl Douglas

Anciens postes connus de Earl Douglas

SociétésPosteFin
General Counsel 01/05/2015
General Counsel 20/04/2012
General Counsel 01/12/2002
Corporate Officer/Principal 01/10/2000
General Counsel -
Voir l'expérience en détail de Earl Douglas

Formation de Earl Douglas

Massachusetts Institute of Technology Undergraduate Degree
Columbia Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Earl Douglas

Relations

51

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
APPLIED MOLECULAR TRANSPORT INC.

Health Technology

ALLOGENE THERAPEUTICS, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Earl Douglas